Our local DOT drug and alcohol testing centers are located in Hilgard OR and the surrounding areas providing DOT drug testing, DOT alcohol testing and DOT physicals for all DOT modes regulated by Part 40. Same day service is available at our Hilgard OR DOT drug testing facilities and most of our DOT drug testing locations are within minutes of your home or office.
What type of DOT Testing is required?
Coastal Drug Testing provides DOT pre-employment, random, post-accident, reasonable suspicion and return to duty testing at our Hilgard OR DOT drug testing centers.
If you hold a CDL license, a large, medium or a small trucking company, Coastal Drug Testing has a complete DOT compliance package which includes all the requirements to comply with CFR 49 part 40.
All Coastal Drug Testing DOT drug testing centers utilize SAMHSA Certified laboratories and a licensed Medical Review Officer as required by DOT part 40 regulations.
The U.S Department of Transportation (DOT) requires that all DOT regulated "safety sensitive" employees have a negative DOT pre-employment drug test result on file and be actively enrolled in a DOT approved random drug and alcohol random testing pool (consortium).
In addition, if a DOT regulated company has more than one "safety sensitive" employee, the employer must also have a written DOT drug and alcohol policy along with an on-site supervisor that must have completed a reasonable suspicion supervisor training program.
On the road and need a DOT Drug or Alcohol test? No Worries!
To be compliant with DOT regulations, a company's DOT drug and alcohol testing program must have the following components:
- Employee Drug Testing
- Written Drug and Alcohol Policy
- Supervisor Training
- Substance Abuse Referral
- Employee Education
- Random Selection Program
- Post Accident Testing
- Designated Employer Representative
- Federal Chain of Custody Forms
- Part 40 Regulations on File
The Department of Transportation (DOT) has specific drug and alcohol testing requirements for the all transportation modes all DOT agencies.
Our modes included are:
- Federal Motor Carrier Safety Administration (FMCSA)
- Federal Aviation Administration (FAA)
- Federal Transit Administration (FTA)
- United States Coast Guard (USCG)
- Pipeline and Hazardous Materials Safety Administration (PHMSA)
- Federal Railroad Administration (FRA)
Are You Enrolled in a DOT Consortium?
Individuals who are employed in a position designated as "safety sensitive" must be actively enrolled in a random drug and alcohol testing program. Oftentimes, covered employees will join a group of other DOT regulated employees in a random testing program and this is referred to as a DOT Consortium. Generally, an employer who has less than fifty employees or single operators will join the consortium which will comply with the random drug and alcohol testing requirements of 49 CFR Part 40. Employers that have over 50 employees who are regulated by Part 40 may elect to be enrolled in a "stand alone" random testing pool.
The DOT consortium is cost effective and complies with all requirements of 49 CFR Part 40 which mandates that all "safety sensitive" employees be enrolled in a random drug and alcohol testing program.
The Department of Transportation (DOT) has strict regulations requiring regulated companies and independent operators (CDL License Holders) to be an active member of a DOT drug and alcohol Consortium and failure to comply with these regulations can result in significant fines and other DOT sanctions.
We are fully versed in the DOT procedures for pre-employment drug testing, random drug testing, reasonable suspicion drug testing, post-accident drug testing, return to duty drug testing and follow up drug testing.
DOT regulated companies with multiple safety sensitive employees must also have an employee within the company who is assigned as the "designated employer representative" (DER). This is the person responsible for removing any DOT "safety sensitive" employee who is covered by 49 CFR Part 40 from performing a DOT safety sensitive position when a positive drug or alcohol test result has occurred or an employee has refused to take a required DOT test.
If you have recently become a DOT regulated company, within the next 18 months the Department of Transportation (DOT) will conduct a "new entrant" inspection to ensure that you are in compliance with all DOT regulations including the drug and alcohol testing requirements. If you are currently a DOT regulated company, you are subject to regular inspections to ensure compliance.
Avoid DOT fines, penalties and be complaint with all DOT drug and alcohol testing regulations! Coastal Drug Testing can assist small, medium and large DOT companies in complying with all requirements of 49 CFR Part 40.
DOT Drug Testing Locations in Hilgard OR
62157 LOWER PERRY LOOP 4.2 miles
LA GRANDE, OR 97850
710 SUNSET DR STE B 6.8 miles
LA GRANDE, OR 97850
1704 ADAMS AVE 7.5 miles
LA GRANDE, OR 97850
2610 BEARCO LOOP 8.3 miles
LA GRANDE, OR 97850
(Don't see a location near you? Call us (800) 828-7086)
Local Area Info: Ernest Hilgard
Ernest Ropiequet "Jack" Hilgard (July 25, 1904 – October 22, 2001) was an American psychologist and professor at Stanford University. He became famous in the 1950s for his research on hypnosis, especially with regard to pain control. Along with André Muller Weitzenhoffer, Hilgard developed the Stanford Hypnotic Susceptibility Scales. A Review of General Psychology survey, published in 2002, ranked Hilgard as the 29th most cited psychologist of the 20th century.
Born in Belleville, Illinois, Ernest Ropiequet Hilgard was the son of a physician, Dr. George Engelmann Hilgard, and Laura Ropiequet Hilgard. Hilgard was initially drawn to engineering; he received a bachelor's degree in chemical engineering from the University of Illinois in 1924. He then studied psychology, receiving a Ph.D. from Yale University in 1930. He was elected a Fellow of the American Academy of Arts and Sciences in 1958. In 1984 Hilgard was awarded the NAS Award for Scientific Reviewing from the National Academy of Sciences.
Hilgard is specifically known for his theory that a so-called "hidden observer" is created in the mind while hypnosis is taking place. His research on the hidden observer during hypnotic pain management was intended to provide support for his neodissociationist theory. This theory held that a person undergoing hypnosis can still observe his or her own pain without consciously experiencing any suffering. The phenomenon of the "hidden observer" was controversial and critics claimed it could be manufactured by suggestions, indicating that it was possibly no more than an artifact of the instructions given to the research participants.[citation needed] Writing in the late 1970s (Hilgard, E. (1977). Divided consciousness: Multiple controls in human thought and action. New York, NY: Wiley), Ernest Hilgard became convinced that we all have another being sharing our lives. Hilgard termed this entity the hidden observer.